- Measuring addiction propensity and severity: The need for a new instrument, Conway K.P., Levy J., Vanyukov M., Chandler R., Rutter J., Swan G.E., et al., p. 4-12.
- The effectiveness of brief intervention among injured patients with alcohol dependence: Who benefits from brief interventions?, Field C.A., Caetano R., p. 13-20.
- The relationship of quality and price of the psychostimulants cocaine and amphetamine with health care outcomes, Brunt T.M., Van Laar M., Niesink R.J.M., Van Den Brink W., p. 21-29.
- Dimethyltryptamine (DMT): Subjective effects and patterns of use among Australian recreational users, Cakic V., Potkonyak J., Marshall A., p. 30-37.
- The role of drinking locations in university student drinking: Findings from a national web-based survey, Kypri K., Paschall M.J., Langley J.D., Baxter J., Bourdeau B., p. 38-43.
- Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia, Vicknasingam B., Mazlan M., Schottenfeld R.S., Chawarski M.C., p. 44-49.
- Effectiveness of diacetylmorphine versus methadone for the treatment of opioid dependence in women, Oviedo-Joekes E., Guh D., Brissette S., Marchand K., Marsh D., Chettiar J., et al., p. 50-57.
- Bringing the real world into the laboratory: Personal smoking and nonsmoking environments, Conklin C.A., Perkins K.A., Robin N., Mcclernon F.J., Salkeld R.P., p. 58-63.
- Effects of experimental Unemployment, Employment and Punishment analogs on opioid seeking and consumption in heroin-dependent volunteers, Greenwald M.K., p. 64-73.
- Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policies, Green T.C., Bluthenthal R.N., Singer M., Beletsky L., Grau L.E., Marshall P., et al., p. 74-81.
- Decisional balance proportion: Quantifying qualitative data to represent motivation to change among treatment-seeking smokers, Collins S.E., Eck S., Torchalla I., Schröter M., Batra A., p. 82-88.
- The use of administrative data as a substitute for individual screening scores in observational studies related to problematic alcohol or drug use, Sears J.M., Krupski A., Joesch J.M., Estee S.L., He L., Shah M.F., et al., p. 89-96.
- A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period, Bisaga A., Aharonovich E., Cheng W.Y., Levin F.R., Mariani J.J., Raby W.N., et al., p. 97-104.
- A randomized, controlled trial of NRT-aided gradual vs. abrupt cessation in smokers actively trying to quit, Hughes J.R., Solomon L.J., Livingston A.E., Callas P.W., Peters E.N., p. 105-113.
- The role of alcohol misuse in PTSD outcomes for women in community treatment: A secondary analysis of NIDA's Women and Trauma Study, Hien D.A., Campbell A.N.C., Ruglass L.M., Hu M.-C., Killeen T., p. 114-119.
- Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers, Levin K.H., Copersino M.L., Heishman S.J., Liu F., Kelly D.L., Boggs D.L., et al., p. 120-127.
- Adolescents' expectancies for smoking to regulate affect predict smoking behavior and nicotine dependence over time, Heinz A.J., Kassel J.D., Berbaum M., Mermelstein R., p. 128-135.
- Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago, Boodram B., Golub E.T., Ouellet L.J., p. 136-145.
- The dimensionality of alcohol use disorders: Results from Israel, Shmulewitz D., Keyes K., Beseler C., Aharonovich E., Aivadyan C., Spivak B., et al., p. 146-154.
- In vivo evidence for long-term CNS toxicity, associated with chronic binge use of methamphetamine, Chung Y.A., Peterson B.S., Yoon S.J., Cho S.-N., Chai S., Jeong J., et al., p. 155-160.
- The effect of motivational status on treatment outcome in the North American Opiate Medication Initiative (NAOMI) study, Nosyk B., Geller J., Guh D.P., Oviedo-Joekes E., Brissette S., Marsh D.C., et al., p. 161-165.
- Retention in naltrexone implant treatment for opioid dependence, Kunøe N., Lobmaier P., Vederhus J.K., Hjerkinn B., Hegstad S., Gossop M., et al., p. 166-169.
- Substance abusers' motives for using anabolic androgenic steroids, Petersson A., Bengtsson J., Voltaire-Carlsson A., Thiblin I., p. 170-172.
- Determinants of alcohol consumption in HIV-uninfected injection drug users, Sander P.M., Cole S.R., Ostrow D.G., Mehta S.H., Kirk G.D., p. 173-176.
- Generalizability of clinical trials for cannabis dependence to community samples, Okuda M., Hasin D.S., Olfson M., Khan S.S., Nunes E.V., Montoya I., et al., p. 177-181.